IMM 5.36% 29.5¢ immutep limited

endpoints for immunotherapy, page-10

  1. 1,234 Posts.
    lightbulb Created with Sketch. 97
    The first one approved by FDA was provenge By Dndreon ,a similar PFS at ph2 to cvac and a similar dendritic treatment focussing on muc1 secreting tumours.
    OS proved to be vey good and hence FDA approval but it was a very bumpy ride to approval. Just look at dendreon's chart over the years leading to approval.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.